Lung Cancers Completed Phase 2 Trials for Exisulind (DB06246)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00041054Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung CancerTreatment
NCT00041314Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung CancerTreatment